NCT07084480 Giant Cell Arteritis - Ways to Precision Medicine
| NCT ID | NCT07084480 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wuerzburg University Hospital |
| Condition | Giant Cell Arteritis |
| Study Type | OBSERVATIONAL |
| Enrollment | 400 participants |
| Start Date | 2025-11-14 |
| Primary Completion | 2030-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 400 participants in total. It began in 2025-11-14 with a primary completion date of 2030-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Eligibility Criteria
Inclusion Criteria: * Age greater or similar to 18 years * Primary diagnosis of GCA or PMR Exclusion Criteria: * Age under 18 years * lack of capacity to consent
Contact & Investigator
Michael Gernert
PRINCIPAL INVESTIGATOR
Wuerzburg University Hospital
Frequently Asked Questions
Who can join the NCT07084480 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Giant Cell Arteritis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07084480 currently recruiting?
Yes, NCT07084480 is actively recruiting participants. Contact the research team at gernert_m1@ukw.de for enrollment information.
Where is the NCT07084480 trial being conducted?
This trial is being conducted at Würzburg, Germany.
Who is sponsoring the NCT07084480 clinical trial?
NCT07084480 is sponsored by Wuerzburg University Hospital. The principal investigator is Michael Gernert at Wuerzburg University Hospital. The trial plans to enroll 400 participants.